PRESS RELEASE published on 05/24/2023 at 02:35, 1 year 4 months ago Fury Files 2023 Shareholder Meeting Proxy Circular
PRESS RELEASE published on 05/16/2023 at 13:00, 1 year 4 months ago Fury Announces Board and Executive Changes
PRESS RELEASE published on 04/13/2023 at 13:00, 1 year 5 months ago Fury Commences 2023 Drill Program at the Eau Claire Deposit
PRESS RELEASE published on 04/11/2023 at 13:00, 1 year 5 months ago Fury Announces 2023 Eau Claire Exploration Program Focusing on Expanding Known Mineralized Zones and Advancing Early Stage Exploration Targets
PRESS RELEASE published on 03/23/2023 at 13:30, 1 year 6 months ago Fury Announces Closing of C$8.75 Million Financing
PRESS RELEASE published on 02/22/2023 at 13:00, 1 year 7 months ago Fury Appoints Brian Christie as New Board Director
PRESS RELEASE published on 02/13/2023 at 13:00, 1 year 7 months ago Fury Defines Six Targets Along the Cannard Deformation Zone at Lac Clarkie
PRESS RELEASE published on 01/23/2023 at 13:00, 1 year 8 months ago Fury Drills Multiple Zones of High-Grade Gold at the Hinge Target including 22.77 g/t Gold over 1.5 Metres
Published on 09/28/2024 at 02:06, 16 hours 51 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 16 hours 57 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 16 hours 57 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 18 hours 47 minutes ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 4 hours 56 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 20 hours 27 minutes ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 21 hours 1 minute ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 17:45, 1 day 1 hour ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 1 hour ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024